99% Purity Enoxaparin Sodium Powder Pharmaceutical Intermediate Enoxaparin Sodium Powder Enoxaparin Sodium

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: D-sung Enoxaparin sodium
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No: 679809-58-6
• Mf: C42h59n3na4o35s2
• MW: 288.42800
• pH: 6.2-7.7
• Stored Temperature: 2-8 C
• Solubility: H2O: 50mg/Ml, Clarified, Slightly Yellow Liquid
• Safety Instructions: 22-24-26-36/37
• Model No.: D-Sung Enoxaparin Sodium
• Product Name: Enoxaparin Sodium
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• HS Code: 3001900190
• Production Capacity: 10000kg/Month

Product Description

 

Product Description

99% purity Enoxaparin sodium powder Pharmaceutical Intermediate Enoxaparin sodium powder
Enoxaparin sodium
 

Product Description

Product Details

 

 

Product Name	Enoxaparin Sodium
Appearance	White Powder
CAS No	679809-58-6
MF	C57H82N4Na4O53S3

It is a natural glycosaminoglycan anticoagulant, which can be used to treat and prevent deep vein thrombosis, pulmonary embolism, arterial embolism, and it can also be used to treat myocardial infarction and unstable angina pectoris. It is usually administered by intravenous injection, but can also be used in blood collection tubes and hemodialysis machines.

Application&Function

Enoxaparin sodium is a low molecular weight heparin obtained from bovine mucosal heparin by chemical depolymerization. It has more potent antithrombotic and profibrinolytic activity than heparin evidenced by its higher activity in inhibiting factor Xa and in reducing plasma activity of platelet activator inhibitor. It is effective in improving the venous blood outflow of lower limbs in deep vein thrombosis (DVT) patients in addition to preventing DVT following orthopaedic surgery, reportedly without
causing bleeding complications. Parnaparin has also shown efficacy in inflammatory occlusive complications of postphlebitic syndrome and in acute myocardial infarction.
Chemical PropertiesWhite or pale-colored amorphous powder; nearly odorless; hygroscopic. Soluble in
water; insoluble in alcohol, benzene, and ether; pH in 17% solution between 5.0 and 7.5.

Specification